KLOW is a multi-component research bundle comprising four individually characterised peptides: BPC-157 (pentadecapeptide, 15 amino acids), TB-500 (Thymosin Beta-4 fragment), GHK-Cu (copper-binding tripeptide), and KPV (anti-inflammatory tripeptide from α-MSH). This bundle is designed for researchers conducting multi-target laboratory studies, as each component has been independently investigated in published literature across distinct signalling pathways — including nitric oxide modulation (BPC-157), actin cytoskeleton dynamics (TB-500), extracellular matrix remodelling (GHK-Cu), and NF-κB inflammatory cascade research (KPV). All components are supplied in lyophilised powder form for controlled experimental use.
This product is intended strictly for laboratory research use only. It is not approved for human or veterinary consumption or for use in diagnostic or therapeutic procedures.